We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+13.55%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$578M
AUM Growth
-$127M
Cap. Flow
-$135M
Cap. Flow %
-23.4%
Top 10 Hldgs %
10.06%
Holding
378
New
127
Increased
22
Reduced
88
Closed
132

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$6.34M
2
IONQ icon
IonQ
IONQ
+$6M
3
SMTC icon
Semtech
SMTC
+$5.94M
4
SITM icon
SiTime
SITM
+$5.93M
5
EXEL icon
Exelixis
EXEL
+$5.92M

Sector Composition

Rank Sector Weight
1 Healthcare 26.46%
2 Technology 16.44%
3 Financials 15.27%
4 Consumer Staples 9.63%
5 Consumer Discretionary 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUR icon
101
Aurora
AUR
$13.8B
$2.76M 0.48%
+410,809
New +$2.94M
ATRC icon
102
AtriCure
ATRC
$2.06B
$2.76M 0.48%
+85,525
New +$3.17M
MWA icon
103
Mueller Water Products
MWA
$4.19B
$2.76M 0.48%
108,473
-103,595
-49% -$2.6M
ROOT icon
104
Root
ROOT
$813M
$2.72M 0.47%
+20,403
New +$2.34M
MP icon
105
MP Materials
MP
$8.99B
$2.72M 0.47%
+111,482
New +$2.59M
GPOR icon
106
Gulfport Energy Corp
GPOR
$2.83B
$2.72M 0.47%
14,768
-8,801
-37% -$1.6M
CASH icon
107
Pathward Financial
CASH
$1.84B
$2.69M 0.47%
36,919
-10,202
-22% -$778K
TVTX icon
108
Travere Therapeutics
TVTX
$5.85B
$2.69M 0.47%
+150,286
New +$3.05M
TARS icon
109
Tarsus Pharmaceuticals
TARS
$2.89B
$2.69M 0.47%
52,413
-19,402
-27% -$959K
GRND icon
110
Grindr
GRND
$2.94B
$2.69M 0.47%
150,278
-44,333
-23% -$778K
INOD icon
111
Innodata
INOD
$2.03B
$2.69M 0.47%
74,905
+52,420
+233% +$2.3M
AKRO
112
DELISTED
Akero Therapeutics
AKRO
$2.69M 0.46%
+66,422
New +$2.82M
DCTH icon
113
Delcath Systems
DCTH
$540M
$2.66M 0.46%
208,604
+143,157
+219% +$2.03M
MLYS icon
114
Mineralys Therapeutics
MLYS
$2.41B
$2.61M 0.45%
+164,273
New +$1.89M
EZPW icon
115
Ezcorp Inc
EZPW
$1.71B
$2.61M 0.45%
+177,104
New +$2.34M
KGS icon
116
Kodiak Gas Services
KGS
$5.81B
$2.56M 0.44%
68,590
-53,886
-44% -$2.3M
AIT icon
117
Applied Industrial Technologies
AIT
$13.3B
$2.55M 0.44%
11,315
-12,431
-52% -$3.06M
PAY icon
118
Paymentus
PAY
$4.91B
$2.54M 0.44%
97,155
-27,408
-22% -$812K
TPL icon
119
Texas Pacific Land
TPL
$24.2B
$2.51M 0.43%
5,688
-24
-0.4% -$10.7K
AVPT icon
120
AvePoint
AVPT
$2.71B
$2.49M 0.43%
172,660
-104,269
-38% -$1.75M
SEI
121
Solaris Energy Infrastructure
SEI
$3.52B
$2.46M 0.43%
112,967
-86,034
-43% -$2.39M
TTMI icon
122
TTM Technologies
TTMI
$14.7B
$2.45M 0.42%
119,638
-34,298
-22% -$829K
UPST icon
123
Upstart Holdings
UPST
$2.95B
$2.4M 0.41%
52,053
-33,503
-39% -$2.08M
RYTM icon
124
Rhythm Pharmaceuticals
RYTM
$7.83B
$2.39M 0.41%
45,108
-17,970
-28% -$997K
GEO icon
125
The GEO Group
GEO
$4.08B
$2.38M 0.41%
+81,650
New +$2.34M

Similar funds

EAM Investors's Q1 2025 Portfolio in Review

As of Q1 2025, EAM Investors held 378 positions worth $578M, down 18% from $706M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors withdrew a net $135M in Q1 2025, closing 132 positions and reducing 88 holdings. Its most notable exit was Glaukos, an estimated $6.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

Against the trend, EAM Investors opened a new position in Carpenter Technology worth $5.98M.

  • EAM Investors's largest Q1 2025 buy was Carpenter Technology: 33,024 shares worth $5.98M.
  • EAM Investors added most to Axogen in Q1 2025, an estimated $3.68M increase.
  • EAM Investors's biggest Q1 2025 reduction was Credo Technology Group, cutting an estimated $5.04M.
  • EAM Investors fully exited Glaukos in Q1 2025, selling an estimated $6.34M.
  • EAM Investors's ten largest holdings make up 10% of its $578M portfolio in Q1 2025.
  • EAM Investors opened 127 new positions and closed 132 in Q1 2025.
  • EAM Investors's portfolio value fell 18% quarter-over-quarter to $578M.

Based on EAM Investors's 13F filing for Q1 2025, filed 13 May 2025.